The European Food Safety Authority (EFSA) has taken a significant step toward expanding the permissible applications of a genetically engineered food enzyme, potentially opening new doors for dairy processors while raising questions about the boundaries of genetically modified organisms in Europe's food chain. The move is set to trigger reactions from biotechnology companies, dairy producers, consumer advocacy groups, and environmental organizations concerned about GMO proliferation.
This assessment comes from EFSA's Panel on Food Contact Materials, Enzymes and Processing Aids (CEP), published on April 1, 2026, as a Scientific Opinion evaluating the safety of extending the use of triacylglycerol lipase from the genetically modified Aspergillus oryzae strain NZYM-FL. The document represents a non-binding scientific risk assessment rather than legislation, but carries significant weight in subsequent regulatory decisions by the European Commission and member states.
The opinion contains concrete scientific conclusions about safety thresholds and specific proposed uses, including measurable exposure assessments and defined conditions of use, rather than vague commitments. EFSA's scientific methodology provides detailed numerical safety margins and specific application scenarios for the enzyme's extended use.
The policy direction reveals a tension between technological innovation in food processing and maintaining strict GMO oversight in the EU food supply. EFSA appears to prioritize scientific risk assessment over precautionary restrictions, potentially easing regulatory barriers for specific, well-characterized GMO applications while maintaining rigorous safety evaluation protocols. This represents a case-by-case approach to GMO regulation rather than blanket restrictions.
For biotechnology companies developing food enzymes, this represents a moderate positive impact as it could expand market opportunities for their products. Dairy processors would experience moderate benefits through access to improved processing aids. Consumer groups face mixed impacts - potential for better quality products but concerns about GMO transparency. Environmental organizations would likely view this as a negative development, seeing it as incremental normalization of GMOs in food production.
This scientific opinion initiates the regulatory process, with the European Commission expected to draft implementing legislation based on EFSA's assessment. National authorities will then need to implement these changes, and the European Parliament may scrutinize the Commission's proposal, making this the beginning of a multi-stage regulatory journey.